Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S. Goldman.
Rasburicase: Potential role in managing tumor lysis in patients with hematological malignancies.
Expert Rev Anticancer Ther, 3 (2003), pp. 89-93
[2.]
M.T. Holdsworth.
Role of iv allopurinol and rasburicase in tumor lysis syndrome.
Am J Healt-Syst Pharm, 60 (2003), pp. 2213-2222
[3.]
C.H. Pui, S. Jeha, D. Irwin, B. Camitta.
Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: Results of a compassionate-use trial.
Leukemia, 15 (2001), pp. 1505-1509
[4.]
L.F. Cohen, J.E. Balow, I.T. Magrath, D.G. Poplack, J.L. Ziegler.
Acute tumor lysis syndrome. A review of 37 patients with Burkitt’s lymphoma.
Am J Med, 68 (1980), pp. 486-491
[5.]
F.B. Stapleton, D.R. Strother, S.D. Roy, R.J. Wyatt, C.P. McKay, S.B. Murphy.
Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma.
Pediatrics, 82 (1988), pp. 863-869
[6.]
W.P. Bowman, J.J. Shuster, B. Cook, T. Griffin, F. Behm, J. Pullen, et al.
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study.
J Clin Oncol, 14 (1996), pp. 1252-1261
[7.]
C. Patte, C. Sakiroglu, S. Ansoborlo, A. Baruchel, E. Plouvier, H. Pacquement, et al.
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia treated in the Société Française d’Oncologie Pédiatrique LMB89 protocol.
Ann Oncol, 13 (2002), pp. 789-795
[8.]
A. Lee, C. Li, K. So, R. Chan.
Treatment of impending tumor lysis with single-dose rasburicase.
Ann Pharmacother, 37 (2003), pp. 1614-1617
[9.]
T.M. Arnold, J.P. Reuter, B.S. Delman, C.B. Shanholtz.
Use of single-dose rasburicase in an obese female.
Ann Pharmacother, 38 (2004), pp. 1428-1431
[10.]
M. Hummel, D. Buchheidt, S. Reiter, J. Bergman, R. Hofheinz, R. Hehlman.
Succesful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.
Leukemia, 17 (2003), pp. 2542-2544
Copyright © 2006. Asociación Española de Pediatría
